Real Talk About Breast Cancer

[00:00:00] Adam Walker: From Susan G Komen, This is Real Pink, a podcast exploring real stories, struggles, and triumphs related to breast cancer. We’re taking the conversation from the doctor’s office to your living room. This is Real Talk, a podcast conversation where we’re digging deep into breast cancer and the realities patients and survivors…

[00:00:00] Adam Walker: From Susan G Komen, this is Real Pink. A podcast exploring real stories, struggles, and triumphs related to breast cancer. We’re taking the conversation from the doctor’s office to your living room. We are lucky to be joined today by actress, mother, breast cancer survivor, and the newest Komen ambassador, Nicole Eggert.…

[00:00:00] Adam Walker: Support for the Real Pink podcast comes from Merck. From Susan G Komen, this is Real Pink, a podcast exploring real stories, struggles, and triumphs related to breast cancer. We’re taking the conversation from the doctor’s office to your living room. Welcome to another powerful episode of the Komen Health Equity Revolution…

[00:00:00] Adam Walker: From Susan G Komen, this is Real Pink. A podcast exploring real stories, struggles, and triumphs related to breast cancer. We’re taking the conversation from the doctor’s office to your living room. [00:00:17] This is Real Talk, a podcast conversation where we’re digging deep into breast cancer and the realities patients and…

On today’s episode, we are discussing a topic that affects most women with hormone receptor-positive, early-stage breast cancer after they finish their initial treatment and begin navigating survivorship. To lower the risk of recurrence, most women begin taking anti-estrogen therapy, also called hormone therapy or endocrine therapy, but these treatments do not come without the risk of side effects. When side effects become severe, survivors may be faced with the task of weighing the benefits of hormone therapy against the associated side effects. This can be challenging and may even lead them to wonder how much longer they need to continue on the medication. Joining us today to discuss how patients and providers can balance fear of recurrence against potential side effects of treatment and how genomic testing can help guide treatment decisions is a Nurse Practitioner at Memorial Sloan-Kettering Cancer Center, Adriana Olivo.

[00:00:00] Adam Walker: This episode of the Real Pink Podcast is brought to you by AstraZeneca. AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all of its complexities to discover, develop, and deliver life changing medicines to patients.…